E&C Announces Hearing on Protecting Scientific Integrity in COVID-19 Response
The Energy and Commerce Committee today announced a Health Subcommittee Hearing for Thursday, May 14, entitled “Protecting Scientific Integrity in the COVID-19 Response.” The hearing notice follows this note to the media.
NOTE TO THE MEDIA:
Due to COVID-19, the Committee will make every effort to adhere to the safety recommendations from the Centers for Disease Control and Prevention (CDC) and the Attending Physician. Therefore, media access will be limited. Please contact your respective gallery for details. As always, congressional press credentials will be required.
May 7, 2020
TO: Members of the Subcommittee on Health
FROM: Anna G. Eshoo, Chairwoman
SUBJECT: Subcommittee Hearing on “Protecting Scientific Integrity in the COVID-19 Response”
The Subcommittee on Health of the Committee on Energy and Commerce will hold a hearing on Thursday, May 14, 2020, at 10 a.m. in the John D. Dingell Room, 2123 of the Rayburn House Office Building. The hearing is entitled, “Protecting Scientific Integrity in the COVID-19 Response.” Witnesses will be by invitation only. Among the witnesses invited to testify is Dr. Rick A. Bright, former Director of the Biomedical Advanced Research and Development Authority.
The logistics of this hearing will be different due to the current circumstances of conducting a public hearing during the COVID-19 pandemic. Members will be advised regarding specifics on hearing procedures and briefings as soon as they become finalized.
If you have any questions, please contact Meghan Mullon with the Committee staff at (202) 225-2927.
The U.S. House of Representatives Office Buildings and the U.S. Capitol Complex are currently closed to the public. Official meetings of the Committee and its subcommittees are broadcast and available on the Committee’s website: www.energycommerce.house.gov.